Compare Mondaycom Ltd (MNDY) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mondaycom Ltd vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Mondaycom Ltd trades at $88.99 (market cap $3.53B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Mondaycom Ltd is far larger — about 2.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Mondaycom Ltd is more actively traded (583,371 versus 5,448,712). Which is the better fit depends on your goals — on Pluang, investors hold Mondaycom Ltd for 16 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| MNDY | NUVB | |
|---|---|---|
Market Cap | $3.53B | $1.71B |
Volume | 583,371 | 5,448,712 |
Sector | Technology | Health |
52-Week High | $205.24 | $9.54 |
52-Week Low | $58.81 | $3.41 |
Typical Hold Time | 16 Days | 0 Days |
Enterprise Value | $2.69B | $1.30B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Monday.com (MNDY) trades at $83.51, down 0.93% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with revenue growth from $1.2B in 2025 to $1.4B in 2026 and consistent earnings beats. Recent news highlights its inclusion in growth stock lists and an upcoming AI-focused conference, Elevate '26.
The outlook is positive given analyst consensus of $110.42 price target and 65% buy ratings, but risks include competitive pressure from Meta's enterprise push and volatile cash flow trends. Investment appeal hinges on execution of AI initiatives and high-value client growth against premium valuations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
